🇺🇸 FDA
Patent

US 11306122

Compositions and methods of inhibiting the binding of plasma IgG autoantibodies to serotonin 2A receptor

granted A61KA61K31/445A61K31/517

Quick answer

US patent 11306122 (Compositions and methods of inhibiting the binding of plasma IgG autoantibodies to serotonin 2A receptor) held by United States Government as represented by the Department of Veterans Affairs expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/445, A61K31/517, A61K38/10, A61P